Cover Image

Reconsidering the gamma–delta shift as a biomarker of antidepressant effects of ketamine enantiomers

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Kenji Hashimoto
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	British Journal of Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Differential effects of ketamine enantiomers on EEG parameters including the gamma‐delta shift phenomenon
by: Szabolcs Koncz, et al.
Published: (2026)

Pharmacokinetics and pharmacodynamics of intravenous and oral (S)‐ketamine: Investigating metabolite contribution to subjective effects
by: Marije E. Otto, et al.
Published: (2026)

Exploring the antidepressant potential of Yueju Pill: Insights from traditional Chinese medicine
by: Xinyan Wu, et al.
Published: (2026)

Sevoflurane acts as an antidepressant by suppression of GluN2D‐containing NMDA receptors on interneurons
by: Fei Guo, et al.
Published: (2024)

Setting of initiation and factors associated with antidepressant use on entry to long‐term care facilities
by: Georgina A. Hughes, et al.
Published: (2025)

Contribution of peripheral and central delta opioid receptors in the relief of migraine‐like headache in female and male rats
by: Manon Dussol, et al.
Published: (2025)

Reconsidering the microbial origins of primary sclerosing cholangitis and related autoimmune disorders: A case for the antro‐duodenal microbiome
by: Richard Kellermayer, et al.
Published: (2025)

Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer
by: Ana Rita Simoes, et al.
Published: (2025)

Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain
by: Siddhesh S. Sabnis, et al.
Published: (2024)

Colchicine effect on biomarkers of cardiac remodelling and atherosclerosis in ST‐elevation myocardial infarction: A randomized controlled trial
by: Hanan Ahmed Hassanain, et al.
Published: (2024)

Identification of prokineticin‐2 as potential pharmacodynamic biomarker for overcoming doxorubicin resistance in multicellular breast cancer spheroids
by: Martina Vincenzi, et al.
Published: (2025)

EpigenPlot: An interactive web platform for DNA methylation‐based biomarker and drug target discovery in colorectal cancer
by: Dalma Müller, et al.
Published: (2025)

PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells
by: Dennis Reininger, et al.
Published: (2024)

Extracellular ATP inhibits excitatory synaptic input on parvalbumin positive interneurons and attenuates gamma oscillations via P2X4 receptors
by: Florian Wildner, et al.
Published: (2024)

Assessment of individual disciplines before and after a shift to an active‐learning and integrated curriculum
by: Ivy Click, et al.
Published: (2025)

Off‐target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
by: Francisco Alejandro Lagunas‐Rangel, et al.
Published: (2024)

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice
by: Mees H. P. Stoop, et al.
Published: (2026)

Neurofilament light chain as in vitro and clinical biomarker of vincristine‐induced peripheral neuropathy
by: Peter Erik Lotko Pontoppidan, et al.
Published: (2026)

Evaluation of the antihypertensive and antihyperlipidaemic effects of a pyrimidine derivative in preventing cardiometabolic risk
by: Baskar Aswinanand, et al.
Published: (2026)

Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy
by: H. Ongun Onaran, et al.
Published: (2024)

Dual effects of mefenamic acid on the IKs molecular complex
by: Magnus Chan, et al.
Published: (2024)

Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry
by: Juliana Salazar, et al.
Published: (2024)

Quantitative relationship between tominersen concentrations in cerebrospinal fluid and biomarker changes in Huntington's disease patients
by: Yumi Yamamoto, et al.
Published: (2025)

JAK–STAT inhibitory effect of IN‐115314, a novel small molecule inhibitor, and pharmacokinetic/pharmacodynamic study in canine
by: Jae‐Hun Ahn, et al.
Published: (2025)

Biphasic effect of nicotine on glutamatergic activity in male mouse brain
by: Prajakta Pramod Biyani, et al.
Published: (2025)

Pharmacological and behavioural effects of tryptamines present in psilocybin‐containing mushrooms
by: Ryan J. Rakoczy, et al.
Published: (2024)

Anti‐inflammatory and remyelinating effects of fexagratinib in experimental multiple sclerosis
by: Fynn Gurski, et al.
Published: (2024)

Establishing reference ranges for circulating biomarkers of drug‐induced liver injury in healthy human volunteers 1
by: Andrea L. Jorgensen, et al.
Published: (2024)

Beneficial effects of CHF6467, a modified human nerve growth factor, in experimental neonatal hypoxic–ischaemic encephalopathy
by: Elisa Landucci, et al.
Published: (2024)

Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin‐induced hearing loss
by: Anna Pisani, et al.
Published: (2024)

Have plastic culture models prevented the discovery of effective cancer therapeutics?
by: Kevin M. Tharp
Published: (2024)

Network medicine and systems pharmacology approaches to predicting adverse drug effects
by: Alessio Funari, et al.
Published: (2024)

Circadian time‐dependent effects of experimental colitis on theophylline disposition and toxicity
by: Yi Yang, et al.
Published: (2024)

Oral vancomycin solution is superior to capsule in inducing clinical biomarker and endoscopic remission in children with atypical ulcerative colitis
by: Laura Räisänen, et al.
Published: (2025)

Artemisinins in autoimmune diseases: effects and mechanisms in systemic lupus erythematosus and rheumatoid arthritis
by: Fanchao Zhou, et al.
Published: (2025)

Transcriptional and functional effects of mavacamten in multiple porcine and human models with hypertrophic cardiomyopathy
by: Elisa Kiselev, et al.
Published: (2025)

Regulation, effects and monitoring of compartmented cGMP signalling in cardiomyocytes—current status
by: Kjetil Wessel Andressen, et al.
Published: (2025)

Sex differences in the vasoactive effect of transient receptor potential channels: TRPM3 as a new therapeutic target for (neuro)vascular disorders
by: Eduardo Rivera‐Mancilla, et al.
Published: (2025)

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients
by: Dávid Nagy, et al.
Published: (2025)

Diltiazem N‐oxide, a novel ischaemia‐activated prodrug, prevents ischaemia‐induced ventricular fibrillation without off‐target adverse effects
by: Louise M. Hesketh, et al.
Published: (2026)